Creative Biogene

Creative Biogene is a biotechnology company specializing in viral vector manufacturing, cell engineering, and RNA therapeutic development. The company operates multiple integrated platforms:

Viral Vector Manufacturing (QVirus™ Platform): Offers GMP-capable design, development, and manufacturing of lentivirus, AAV, adenovirus, and retrovirus vectors with high titer and large delivery viral counts. Supports viral vaccine development, gene therapy, and oncolytic virus applications.

Cell Line Development: Provides transfected and engineered stable cell lines including reporter, kinase, immune receptor, biosimilar, Cas9, and knockout variants. Offers ready-to-assay cells and specialized lines for ADCC/ADCP, immune checkpoint, and CAR-T applications.

RNA Therapeutics (IntegrateRNA Platform): Develops circular RNA, self-amplifying RNA (saRNA), and tRNA in vitro synthesis platforms. Provides GalNAc-oligonucleotide conjugation, lipid nanoparticle (LNP) formulation, and high-throughput LNP screening services for nucleic acid delivery optimization.

Microbial & Bioprocess Services: Offers strain development, cell banking, upstream process (USP) development, downstream process (DSP) development, analytics development, and manufacturing scale-up with quality control support.

Research Reagents & Tools: Supplies premade virus particles, virus-like particles (VLPs), recombinant proteins, clones, kits, enzymes, aptamers, and adjuvants for drug screening and target validation.